Quantcast

Posts related to ‘Dendreon earnings’

biotech

Dendreon Shows Poor Provenge Sales, Implosion Risk Rising

Posted: May 9, 2013 at 10:25 am

Dendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming ...
Read Full Story »

Dendreon, Biotech Cult Firm, Cuts Workers, Posts Earnings–Shares Off 18%

Posted: July 30, 2012 at 6:13 pm

Dendreon (NASDAQ: DNDN), the small biotech firm with a cult following a among Wall St. traders, posted earnings today and slashed its staff.  The stock dropped immediately after the news, and ...
Read Full Story »

Dendreon, When 200% Sales Growth Is Not Enough (DNDN)

Posted: May 7, 2012 at 4:47 pm

Dendreon Corporation (NASDAQ: DNDN) has reported its quarterly results and the reaction is a bit cool. This is growth of almost 200%, as net product revenue for the quarter was ...
Read Full Story »

The 8 Earnings Reports Shaping The Week Ahead (DNDN, EA, RAX, DIS, CSCO, M, NUAN)

Posted: May 4, 2012 at 3:52 pm

24/7 Wall St. often looks at the key earnings reports scheduled for the week ahead.  We have the bulk of the S&P 500 earnings behind us and we are now ...
Read Full Story »

Top Earnings Previews For The Week Ahead (CIM, HUM, ADM, COH, DRYS, DUK, OPEN, PFE, SIRI, AWK, CLX, CMCSA, DNDN, GRMN, WFR, TSLA, ZIP, AIG, CVS, DF, FSLR, KFT, LNKD, PCLN, LUV, PG)

Posted: July 29, 2011 at 1:51 pm

We have another very busy earnings week ahead for the second quarter reporting season.  Some are DJIA components and some are sector-movers or market-movers.  We are tracking earnings and giving ...
Read Full Story »